Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
4(66.7%)
N/A
2(33.3%)
6Total
Phase 4(4)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT03458572Not ApplicableCompleted

Acupuncture for Prevention of Itch in Caesarean Section

Role: collaborator

NCT04394533Phase 4Recruiting

Hyperbaric Prilocaine Compared With Hyperbaric Bupivacaine in Cervical Cerclage?

Role: collaborator

NCT05726760Unknown

Peripheral Skin Temperature Changes Following Spinal Anaesthesia for Category 4 LSCS

Role: collaborator

NCT02221531Phase 4Completed

Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioN

Role: collaborator

NCT03220997Not ApplicableUnknown

Do Preoperative Carbohydrate Drinks Prevent Preoperative Catabolism in Mothers Undergoing Elective Caesarean Section? A Randomised Controlled Study

Role: collaborator

NCT01243970Phase 4Terminated

Ephedrine vs Phenylephrine - ECG Changes

Role: collaborator

NCT02116842Phase 4Unknown

Minimum Effective Dose (MED) & Epidural Bupivacaine

Role: collaborator

All 7 trials loaded